Valence ロゴ
人気
ログイン
Loading data for CLOV — first visit, this takes a few seconds.

ウォッチリストに追加

Clover Health Investments...

NasdaqGS: CLOV · リアルタイム株価 · USD
4.22
-0.01 (-0.24%)
終値時点： Aug 20, 2026, 3:59 PM
4.12
+0.45%
時間外: 7:59 PM

株価、主要な数字、最新ニュースをひとまとめにしたページです。

Clover Health Investments Corp.（CLOV）の株価・分析・データ

-0.24%
買気配3.14
時価総額2.18B
売上高（TTM）2.48B
純利益（TTM）-18.36M
2.48
-0.05
n/a
27.33
PBR（TTM）5.77
PSR（TTM）0.88
決算発表日Nov 4, 2025
売気配5.38
出来高2,878,281
平均出来高（20日）6,701,049
始値4.29
前日終値4.23
当日レンジ4.16 - 4.37
52週レンジ1.58 - 5.59
アナリストn/a
目標株価n/a
配当n/a
権利落ち日n/a

CLOVについて

Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It also operates Clover Assistant, a software platform for physicians to detect, identify, and manage chronic diseases. The company was founded in 2014 and is based in Wilmington, Delaware....

[続きを読む]
業種 Healthcare Plans
セクター Healthcare
IPO日 Jun 12, 2020
従業員数 724
上場取引所 NasdaqGS
ティッカー CLOV
ウェブサイト https://www.cloverhealth.com
企業情報の全文

業績

2025年のClover Health Investmentsの売上高は1.92Bで、前年の1.37Bから40.34%の増加でした。 利益は-85.55Mで、98.91%の増加でした。

財務諸表

決算サプライズ

Clover Health InvestmentsはAug 5, 2026に四半期決算を発表しました：
  • 売上高は $743.17M で、予想を下回りました $0, うち 55.60% の前年比増加にあたります.
  • EPSは 0.07 で、予想を上回りました 0.02, うち 40.00% の前年比増加にあたります.

    • 次回決算発表

    Clover Health Investments Corp.の決算発表予定日は Nov 4, 2025, 引け後の予定です。
    アナリストの売上高予想は ... アップグレード
    news image

    6日前 · Simply Wall St.

    Is Clover Health Investments (CLOV) Fairly Valued After A 228% Run?

    Clover Health Investments has delivered a very strong 227.7% return over the past 3 years, yet the share price around US$4.49 now lines up with valuation checks that suggest the stock no longer looks ...

    news image

    6日前 · Simply Wall St.

    Does Clover’s Profit Turn and Raised 2026 Guidance Reshape the Bull Case for CLOV?

    Clover Health Investments, Corp. has already reported its second-quarter 2026 results, posting revenue of US$743.17 million versus US$477.62 million a year earlier and moving from a net loss of US$10....

    news image

    6日前 · StockStory

    The 5 Most Interesting Analyst Questions From Clover Health’s Q2 Earnings Call

    Clover Health’s second quarter results were met with a positive market reaction, driven by strong Medicare Advantage membership growth and improved profitability. Management credited the quarter’s per...

    news image

    1週間前 · Motley Fool

    Clover Health (CLOV) Q2 2026 Earnings Call Transcript

    Medicare Advantage membership surged 48% as profitability improved sharply.

    news image

    1週間前 · MarketBeat

    Clover Health Eyes 2026 GAAP Profit as AI Platform Fuels Medicare Advantage Growth

    Clover Health Investments (NASDAQ:CLOV) is positioning its Medicare Advantage model around earlier identification and treatment of chronic conditions, Interim Chief Financial Officer Clay Thornton sai...

    2ページ中1ページ